Loading stock data…
Loading stock data…
US$20.78
Get one email when KARD crosses your level. Checked every 15 minutes during market hours.
▼ -1.21 (-5.50%)down today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
Healthcare · Biotechnology
Kardigan, Inc. is a clinical-stage biotechnology company focused on cardiovascular drug development. It develops medicines aimed at the root causes of specific heart and vascular diseases, using patient data, clinical trial insights, and advanced analytics to identify responders and refine treatment strategies. The company’s work centers on targeted therapies for unmet needs in cardiology, including diseases where approved treatment options remain limited. Kardigan also combines internal researc…
www.kardigan.bioCompanies in the same industry, via Finnhub
RSI (14-day)
44.1
NeutralAbove 70 can signal overbought; below 30, oversold.
Daily values · indicators are descriptive, not trading advice